Deutsch (DE-CH-AT)French (Fr)English (United Kingdom)

ROTEM - The bleeding management system

  • Schrift vergrößern
  • Standard-Schriftgröße
  • Schriftgröße verkleinern
FUNKTIONSWEISE Ergebnisinterpretation
There are no translations available.


Normal patient:


Ergebnisint 121018 NormalerPatient

 

Platelet deficiency:


Ergebnisint 121018 Plaettchenmangel


Fibrinogen deficiency:


Ergebnisint 121018 Fibrinmangel

 

Hyperfibrinolysis:


Ergebnisint 121018 Hyperfibrinolyse

 

 

Heparin influence:

 

Ergebnisint 121018 Heparineinfluss



 

Result Interpretation

 

The assessment of the ROTEM® analysis is carried out along the time axis (from left to right):

A disturbed activation of coagulation is indicated

by a prolonged clotting time. As causes, a factor deficiency or a heparin effect have to be considered. The comparison of INTEM and HEPTEM allows for a specific detection of a heparin effect.


An abnormal clot formation is indicated by a prolonged clot formation time (CFT) and/or a reduced clot firmness (MCF). The CFT is thereby

influenced more strongly by a clot polymerisation disorder than the MCF. A prolonged CFT, with at the same time normal MCF, indicates therefore

a polymerisation disorder, whereas a reduced MCF with a normal CFT rather indicates a deficiency of clottable substrate (fibrinogen and / or

platelets).

Fibrinolysis is detected by the lysis of the clot (ML > 15%) or by the finding of a better clot formation (shorter CFT, greater MCF) in APTEM as compared to EXTEM. Several centres already use, in massive bleeding, a shortening of the CT in APTEM, as compared to EXTEM, as a trigger for an antifibrinolytic drug administration.

 

In summary the ROTEM® analysis provides:

  • Rapid information from the beginning of clot formation until its dissolution
  • Concentration and activity of coagulation factors (incl. F XIII)
  • Effects of anticoagulants like heparin or hirudin
  • Fibrin generation and stabilisation
  • Contribution of other drugs (e.g. plasma
    expanders)
  • Platelet count and quality
  • The balance between plasmatic and platelet
    derived contributions to haemostasis
  • (Hyper-) fibrinolysis